Trial intelligence / Profile preview

MicroRNA profiling in hepatitis C surgery patients: propofol versus sevoflurane anesthesia

PACTR201512001375334Not yet recruiting

Sponsor
Science, Technology & Innovation Funding Authority
Start
Dec 2015
Modality
Small Molecules
Countries
1
01

Overview

Open-label trial of propofol and sevoflurane in hepatitis C virus infection (4 arms), sponsored by Science, Technology & Innovation Funding Authority. Primary endpoint: Effect of study drugs on microRNA. Planned start Dec 2015; status: not yet recruiting.

02

Drugs

propofolsevoflurane
03

Conditions

hepatitis C virus infection

Beyond the preview

Go deeper on PACTR201512001375334.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR201512001375334.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call